by Hannah Harris Green on  (#6X6G5)
		Legislation would radically ease research restrictions on cannabis and other schedule I substancesA recently introduced bill, if it passes, would allow research on cannabis despite its schedule I status, which some experts say could help policymakers craft effective" legislation in the future and potentially allow more clinical research on medical cannabis.Representatives Dina Titus and Ilhan Omar introduced the Evidence-Based Drug Policy Act of 2025 (EBDPA) last week, which would radically ease research restrictions on cannabis and other schedule I substances. Continue reading...